Products

The arthroscopy/soft tissue segment reached sales of $4.5 billion in 2015, a four percent increase over 2014, according to ORTHOWORLD estimates. Growth in the market is buoyed by several factors: strength of the main players, smaller players expanding their portfolios to complement other product lines, industry focus and surgeon adoption of minimally invasive techniques and surgeons' push to drive new technologies and techniques in ligament and tendon care and repair.

Cayenne Medical commenced U.S. launch of the BioWick™ SureLock™ implant, an interpositional scaffold wick designed to address the biology issue associated with rotator cuff repair failure.

Proxy Biomedical has developed high strength resorbable USP 2 suture for fracture and soft tissue repair applications. 

Episurf Medical achieved a milestone of 100 accounts approved and connected to the company's proprietary ?ifidelity™ IT platform, used with Episealer® personalized implants and Epiguide® drill guides to treat localized joint cartilage injury.